METTL14 and pancreatic ductal adenocarcinoma: Interestingly, lack of METTL14 leading to increased expression of duct markers such as KRT19, SOX9, MEIS2 could have implications for pancreatic ductal carcinoma which is among the most lethal cancers in humans.